Considerations regarding efficacy endpoints in HIV vaccine trials : Executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine EnterpriseFRUTH, Uli.Vaccine. 2009, Vol 27, Num 14, pp 1989-1996, issn 0264-410X, 8 p.Article

A review of vaccine research and development : TuberculosisGIRARD, Marc P; FRUTH, Uli; KIENY, Marie-Paule et al.Vaccine. 2005, Vol 23, Num 50, pp 5725-5731, issn 0264-410X, 7 p.Article

Sexually transmitted infections: Vaccine develoment for global healthBROUTET, Nathalie; DEAL, Carolyn D; FRUTH, Uli et al.Vaccine. 2014, Vol 32, Num 14, issn 0264-410X, 121 p.Serial Issue

Vaccines for sexually transmitted infections: Past, present and futureFRUTH, Uli; BROUTET, Nathalie; DEAL, Carolyn et al.Vaccine. 2014, Vol 32, Num 14, pp 1525-1526, issn 0264-410X, 2 p.Article

The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and diseaseGARNETT, Geoff P.Vaccine. 2014, Vol 32, Num 14, pp 1536-1542, issn 0264-410X, 7 p.Article

Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agenciesDODET, Betty.Vaccine. 2014, Vol 32, Num 14, pp 1624-1629, issn 0264-410X, 6 p.Article

Current status and prospects for development of a vaccine against Trichomonas vaginalis infectionsSMITH, Jeffrey; GARBER, Gary E.Vaccine. 2014, Vol 32, Num 14, pp 1588-1594, issn 0264-410X, 7 p.Article

Health care professional communication about STI vaccines with adolescents and parentsHOFSTETTER, Annika M; ROSENTHAL, Susan L.Vaccine. 2014, Vol 32, Num 14, pp 1616-1623, issn 0264-410X, 8 p.Article

Current status of syphilis vaccine development: Need, challenges, prospectsCAMERON, Caroline E; LUKEHART, Sheila A.Vaccine. 2014, Vol 32, Num 14, pp 1602-1609, issn 0264-410X, 8 p.Article

Current status and prospects for development of an HSV vaccineJOHNSTON, Christine; KOELLE, David M; WALD, Anna et al.Vaccine. 2014, Vol 32, Num 14, pp 1553-1560, issn 0264-410X, 8 p.Article

Vaccines against sexually transmitted infections: The way forwardBROUTET, Nathalie; FRUTH, Uli; DEAL, Carolyn et al.Vaccine. 2014, Vol 32, Num 14, pp 1630-1637, issn 0264-410X, 8 p.Article

Towards a safe and effective chlamydial vaccine: Lessons from the eyeMABEY, David C. W; HU, Victor; BAILEY, Robin L et al.Vaccine. 2014, Vol 32, Num 14, pp 1572-1578, issn 0264-410X, 7 p.Article

Planning to improve global health : the next decade of tuberculosis controlMAHER, Dermot; DYE, Chris; IGNATIUS, Heather et al.Bulletin of the World Health Organization. 2007, Vol 85, Num 5, pp 341-347, issn 0042-9686, 7 p.Article

Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on Next Generation Herpes Simplex Virus VaccinesKNIPE, David M; COREY, Lawrence; COHEN, Jeffrey I et al.Vaccine. 2014, Vol 32, Num 14, pp 1561-1562, issn 0264-410X, 2 p.Article

Vaccines to promote and protect sexual health: Policy challenges and opportunitiesHAWKES, Sarah; KISMÖDI, Eszter; LARSON, Heidi et al.Vaccine. 2014, Vol 32, Num 14, pp 1610-1615, issn 0264-410X, 6 p.Article

Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infectionsBROTMAN, Rebecca M; RAVEL, Jacques; BAVOIL, Patrik M et al.Vaccine. 2014, Vol 32, Num 14, pp 1543-1552, issn 0264-410X, 10 p.Article

Development status and future prospects for a vaccine against Chlamydia trachomatis infectionHAFNER, Louise M; WILSON, David P; TIMMS, Peter et al.Vaccine. 2014, Vol 32, Num 14, pp 1563-1571, issn 0264-410X, 9 p.Article

Vaccines against gonorrhea: Current status and future challengesJERSE, Ann E; BASH, Margaret C; RUSSELL, Michael W et al.Vaccine. 2014, Vol 32, Num 14, pp 1579-1587, issn 0264-410X, 9 p.Article

A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagentsDOCKRELL, Hazel M; BRAHMBHATT, Shweta; PESSOLANI, Maria Cristina V et al.Infection and immunity. 2000, Vol 68, Num 10, pp 5846-5855, issn 0019-9567Article

HPV vaccines to prevent cervical cancer and genital warts: an updateDOCHEZ, Carine; BOGERS, Johannes J; VERHELST, Rita et al.Vaccine. 2014, Vol 32, Num 14, pp 1595-1601, issn 0264-410X, 7 p.Article

Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccinesGOTTLIEB, Sami L; LOW, Nicola; NEWMAN, Lori M et al.Vaccine. 2014, Vol 32, Num 14, pp 1527-1535, issn 0264-410X, 9 p.Article

New live mycobacterial vaccines : the Geneva consensus on essential steps towards clinical developmentKAMATH, Arun T; FRUTH, Uli; LAMBERT, Paul-Henri et al.Vaccine. 2005, Vol 23, Num 29, pp 3753-3761, issn 0264-410X, 9 p.Article